Barriers or gaps in implementation of misoprostol use for post-abortion care and post-partum hemorrhage prevention in developing countries: a systematic review

[1] Prata N(2013)New hope: community-based misoprostol use to prevent postpartum haemorrhage Health Policy and Planning 28 339-346

[2] Passano P(2013)Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date BMC pregnancy and childbirth 13 44-347

[3] Bell S(2015)Assessing post-abortion care in health facilities in Afghanistan: a cross-sectional study BMC Pregnancy and Childbirth 15 6-13

[4] Rowen T(2013)Shaping legal abortion provision in Ghana: using policy theory to understand provider-related obstacles to policy implementation Health Research Policy and Systems 11 23-3

[5] Potts M(2012)Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum hemorrhage Journal of the Royal Society of Medicine 105 336-S90

[6] Smith JM(2014)Postpartum haemorrhage management, risks, and maternal outcomes: findings from the World Health Organization Multicountry Survey on Maternal and Newborn Health BJOG: An International Journal of Obstetrics & Gynaecology 121 5-284

[7] Gubin R(2007)AMSTAR – a measurement tool to assess the methodological quality of systematic reviews BMC Medical Research Methodology 7 10-175

[8] Holston MM(2004)Risk factors, prevalence, and treatment of anxiety and depressive disorders in Pakistan: systematic review BMJ. 328 794-undefined

[9] Fullerton J(2012)Misoprostol for postpartum hemorrhage: Moving from evidence to practice International Journal of Gynecology & Obstetrics 116 1-undefined

[10] Prata N(2014)Interpretation of National Policy Regarding Community-Based Use of Misoprostol for Postpartum Hemorrhage Prevention in Ethiopia: A Tale of Two Regions Journal of Midwifery & Women’s Health 59 S83-undefined

[1] Prata N(2013)New hope: community-based misoprostol use to prevent postpartum haemorrhage Health Policy and Planning 28 339-346

[2] Passano P(2013)Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date BMC pregnancy and childbirth 13 44-347

[3] Bell S(2015)Assessing post-abortion care in health facilities in Afghanistan: a cross-sectional study BMC Pregnancy and Childbirth 15 6-13

[4] Rowen T(2013)Shaping legal abortion provision in Ghana: using policy theory to understand provider-related obstacles to policy implementation Health Research Policy and Systems 11 23-3

[5] Potts M(2012)Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum hemorrhage Journal of the Royal Society of Medicine 105 336-S90

[6] Smith JM(2014)Postpartum haemorrhage management, risks, and maternal outcomes: findings from the World Health Organization Multicountry Survey on Maternal and Newborn Health BJOG: An International Journal of Obstetrics & Gynaecology 121 5-284

[7] Gubin R(2007)AMSTAR – a measurement tool to assess the methodological quality of systematic reviews BMC Medical Research Methodology 7 10-175

[8] Holston MM(2004)Risk factors, prevalence, and treatment of anxiety and depressive disorders in Pakistan: systematic review BMJ. 328 794-undefined

[9] Fullerton J(2012)Misoprostol for postpartum hemorrhage: Moving from evidence to practice International Journal of Gynecology & Obstetrics 116 1-undefined

[10] Prata N(2014)Interpretation of National Policy Regarding Community-Based Use of Misoprostol for Postpartum Hemorrhage Prevention in Ethiopia: A Tale of Two Regions Journal of Midwifery & Women’s Health 59 S83-undefined